1,10-phenanthroline;  66-71-7;  o-phenanthroline;  Phenanthroline;  4,5-diazaphenanthrene;

1,10-o-phenanthroline;orthophenanthroline;2-phenanthroline;beta-phenanthroline;phen;1,10-Phenanthroline anhydrous;1,10-Fenanthrolin;.beta.-Phenanthroline;[1,10]phenanthroline;MLS000069797;CHEMBL415879;NSC 4265;DTXSID1025857;CHEBI:44975;W4X6ZO7939;NSC-4265;NSC203545;NSC-203545;NSC4265;SMR000058190;DTXCID405857;1,10-Phenanthroline, Anhydrous;MLS002701886;CAS-66-71-7;PHN;1,10-Fenanthrolin [Czech];Activ-8;CCRIS 4855;EINECS 200-629-2;Phenanthroline, 1,10-;MFCD00011678;NSC 203545;phenantroline;UNII-W4X6ZO7939;Cyto5A5;1,10-phenanthrolin;1,10-phenantroline;1,10-phenathroline;1,10 phenanthroline;1,10-Fenanthroline;1.10-phenanthroline;1,1 0-phenanthroline;Opera_ID_711;[1,10]-Phenanthroline;Lopac-P-9375;PHENANTHROLINE, O-;Activ-8 in hexylene glycol;cid_1318;SCHEMBL8312;NCIStruc1_000192;NCIStruc2_000199;Lopac0_000985;O-PHENANTHROLINE [MI];WLN: T B666 CN NNJ;1,10 CPhenanthroline anhydrous;NCI4265;1,10-Phenanthroline (anhydrous);1,10-Phenanthroline, >=99%;HMS2234D03;HMS3263E11;HMS3371F11;ZINC164363;AMY25754;Tox21_201998;Tox21_303111;Tox21_500985;BDBM50092158;CCG-38059;NCGC00013043;s6830;STL069281;AKOS000281773;AC-3314;CS-W004544;DB02365;HY-W004544;LP00985;SDCCGSBI-0050958.P003;NCGC00013043-02;NCGC00013043-03;NCGC00013043-04;NCGC00013043-05;NCGC00013043-06;NCGC00013043-07;NCGC00013043-08;NCGC00013043-09;NCGC00013043-10;NCGC00013043-13;NCGC00091201-01;NCGC00091201-02;NCGC00091201-03;NCGC00091201-04;NCGC00257123-01;NCGC00259547-01;NCGC00261670-01;AC-18353;AS-14043;NCI60_003976;DB-013750;EU-0100985;FT-0606035;FT-0660636;P0221;P0879;P1826;P2099;EN300-35040;C00604;O10332;P 9375;A835532;AA-860/25004133;Q416005;SR-01000076093;CU-00000000156-1;J-610043;SR-01000076093-1;W-104740;F3377-1129;Titration solution for quantitative analysis of butyllithium;1,10-Phenanthroline in combination with isoniazid and rifampicin;

40

1318

180.2

C12H8N2

Shown in network

Show/Hide similarity panel